This Men’s Telehealth Company Has A Unique Take On Telehealth And Products

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

By Johnny Rice, Benzinga

Jacob Cohen, CEO of Mango Rx (NASDAQ: MGRX), was recently a guest on Benzinga’s All-Access.

Mangoceuticals is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the company has identified men's wellness telemedicine services and products as a growing sector especially related to the area of erectile dysfunction (ED), hair growth, and hormone replacement therapies.

Learn more here:

Featured photo by Taylor Grote on Unsplash.

Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

Contact Details

Benzinga

+1 877-440-9464

info@benzinga.com

Company Website

http://www.benzinga.com

View source version on newsdirect.com: https://newsdirect.com/news/this-mens-telehealth-company-has-a-unique-take-on-telehealth-and-products-161364562

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  262.07
+3.44 (1.33%)
AAPL  310.34
+0.99 (0.32%)
AMD  456.75
-16.50 (-3.49%)
BAC  62.33
+0.64 (1.04%)
GOOG  344.59
+2.84 (0.83%)
META  559.02
+9.12 (1.66%)
MSFT  487.31
+4.07 (0.84%)
NVDA  208.48
-6.24 (-2.91%)
ORCL  142.45
-4.02 (-2.74%)
TSLA  348.95
-13.91 (-3.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.